Cognitively normal | MCI | AD | |
---|---|---|---|
(n = 37) | (n = 61) | (n = 65) | |
YKL-40 (ng/ml), baseline | 231 (16) | 304 (16)* | 288 (12)* |
YKL-40 (ng/ml), follow-up | 241 (18) | 320 (16)* | 306 (14)† |
Annual change, (β (SE)) | 5.3 (3.2) | 8.9 (3.0)‡ | 7.1 (3.1)§ |
VILIP-1 (pg/ml), baseline | 168 (11) | 192 (13) | 182 (10) |
VILIP-1 (pg/ml), follow-up | 175 (11) | 217 (14) | 190 (11) |
Annual change, (β (SE)) | 2.8 (2.8) | 10.7 (2.6)‡ | 3.1 (2.6) |